German biotech company to partner with Rwanda

- Advertisement -

BERLIN (CU)_During the past week, COVID-19 vaccinations in the Africa tripled to 13 million doses as donations of vaccines increased from developed nations. However, this still remains a drop in an ocean in a region home to 1.3 billion people, of which only 2.4 per cent has been vaccinated so far. Therefore, with the aim of setting up a sustainable Coronavirus vaccine manufacturing programme in the African continent, the government officials of Rwanda and Senegal met with the top executives of German biotechnology company BioNTech. The President of the European Commission Ursula von der Leyen also participated in the meeting that was held in Berlin on Friday (27 August).  

BioNTech is well known for its recent collaboration with…

Hot this week

World Reacts to Spain’s World Cup 2026 Victory After Extra-Time Goal Ends Argentina’s Defence

Spain's substitute Ferran Torres scored in the 106th minute...

HE Chevalier Nirj Deva DL – Resume

Nirj Deva DL FRSA is unique. The only person...

US Soldier Killed in Iraq as Iran Tensions Continue to Rise

A US service member has been killed in northern...

What Led an Olympic Cyclist to Drive Despite a Ban?

Australian cyclist Rohan Dennis has admitted to driving even...

Northern Mozambique’s Financial Divide: The Battle to Connect Millions to the Digital Economy

With the passing of time, mobile phones connect people...
- Advertisement -

Related Articles

- Advertisement -sitaramatravels.comsitaramatravels.com

Popular Categories